Blog
RSS FeedPosted by Michael Wonder on 11 Apr 2025
13,000 people to benefit from new insulin medicine
11 April 2025 - Pharmac will fund a new type of insulin for people with diabetes, branded as Ryzodeg, from ...
Posted by Michael Wonder on 31 Mar 2025
PHARMAC proposing to fund two brands of oestradiol patches
27 March 2025 - PHARMAC is seeking feedback on a proposal to fund two brands of oestradiol patches for New ...
Posted by Michael Wonder on 12 Mar 2025
PHARMAC to fund more cancer medicines (March 2025)
12 March 2025 - PHARMAC is funding six more medicines for cancers and one for antibiotic resistant infections. ...
Posted by Michael Wonder on 11 Mar 2025
PHARMAC funds new oral contraceptive pill
11 March 2025 - PHARMAC has decided to fund a new progestogen only oral contraceptive pill called desogestrel (Cerazette). ...
Posted by Michael Wonder on 10 Mar 2025
New insulin medicine proposed for people with diabetes
10 March 2025 - PHARMAC is seeking public feedback on a proposal to fund a new, additional type of insulin ...
Posted by Michael Wonder on 01 Feb 2025
New Zealand Pharmaceutical Schedule - 1 February 2025
1 February 2025 - The February 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Nov 2024
New Zealand Pharmaceutical Schedule - 1 November 2024
1 November 2024 - The November 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 10 Oct 2024
PHARMAC improves access to three cancer medicines
10 October 2024 - PHARMAC will improve access to three cancer medicines from 1 November 2024. ...
Posted by Michael Wonder on 18 Sep 2024
Making more new cancer treatments available for New Zealanders
18 September 2024 - PHARMAC is consulting on a proposal to fund the medicine lenvatinib mesylate for three types of cancer ...
Posted by Michael Wonder on 17 Sep 2024
5,700 people to benefit from widened access to funded medicines
17 September 2024 - PHARMAC is widening access to seven medicines, benefitting an estimated 5,700 people within the first year ...
Posted by Michael Wonder on 09 Sep 2024
First cancer medicine decision following PHARMAC funding boost
9 September 2024 - PHARMAC has decided to widen access to two medicines for several types of cancer. ...
Posted by Michael Wonder on 16 Jan 2024
PHARMAC - 2023 in review
17 January 2024 - 2023 was yet another dismal year for New Zealanders in terms of them being able to ...
Posted by Michael Wonder on 16 Sep 2015
Rare disorders process yields first funding decision
15 September 2015 - People with the rare blood condition hereditary angioedema are the first to benefit from the increased competition ...
Posted by Michael Wonder on 11 Sep 2015
PHARMAC request for proposals – supply of progestagen-only long-acting intrauterine systems
11 September 2015 - PHARMAC invites proposals for the supply of progestogen-only long-acting intrauterine systems in New Zealand. ...
Posted by Michael Wonder on 19 Aug 2015
Responses to feedback on PHARMAC's proposed approach to market share procurement of hospital medical devices
19 August 2015 - PHARMAC sought feedback on our proposed approach to market share procurement (MSP) for hospital medical devices in ...